1. Home
  2. HBB vs CNTX Comparison

HBB vs CNTX Comparison

Compare HBB & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

HOLD

Current Price

$19.57

Market Cap

252.9M

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$2.59

Market Cap

283.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBB
CNTX
Founded
1904
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
283.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
HBB
CNTX
Price
$19.57
$2.59
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.60
AVG Volume (30 Days)
15.5K
719.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
17.39
EPS
0.26
N/A
Revenue
$606,852,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$75.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$0.49
52 Week High
$21.84
$3.62

Technical Indicators

Market Signals
Indicator
HBB
CNTX
Relative Strength Index (RSI) 52.60 59.42
Support Level $17.95 $2.10
Resistance Level $20.44 $2.90
Average True Range (ATR) 1.28 0.14
MACD -0.06 0.03
Stochastic Oscillator 60.30 100.00

Price Performance

Historical Comparison
HBB
CNTX

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: